35 related articles for article (PubMed ID: 30197228)
1. Naloxone and nalmefene absorption delivered by hollow microneedles compared to intramuscular injection.
Papich MG; Narayan RJ
Drug Deliv Transl Res; 2022 Feb; 12(2):376-383. PubMed ID: 34817831
[TBL] [Abstract][Full Text] [Related]
2. Nalmefene is effective at reducing alcohol seeking, treating alcohol-cocaine interactions and reducing alcohol-induced histone deacetylases gene expression in blood.
Calleja-Conde J; Echeverry-Alzate V; Giné E; Bühler KM; Nadal R; Maldonado R; Rodríguez de Fonseca F; Gual A; López-Moreno JA
Br J Pharmacol; 2016 Aug; 173(16):2490-505. PubMed ID: 27238566
[TBL] [Abstract][Full Text] [Related]
3. Comment on: Can Intranasal Nalmefene Reduce the Number of Opioid Overdose Deaths?
Skolnick P
Clin Pharmacol Drug Dev; 2024 Mar; 13(3):317-318. PubMed ID: 38289195
[No Abstract] [Full Text] [Related]
4. [Pharmacovigilance. Withdrawal and rebound effects: not just with psychotropic drugs].
Marouf R; Chtioui H; Girardin FR; Buclin T; Diezi L
Rev Med Suisse; 2024 Jan; 20(856-7):96-101. PubMed ID: 38231110
[TBL] [Abstract][Full Text] [Related]
5. [Nalmefene: a novel pharmacotherapeutic option for alcoholism].
Soyka M
Nervenarzt; 2014 May; 85(5):578-82. PubMed ID: 24126432
[TBL] [Abstract][Full Text] [Related]
6. [Nalmefene and Opioid Withdrawal Syndrome: Analysis of the Global Pharmacovigilance Database for Adverse Drug Reactions].
Dahmke H; Kupferschmidt H; Kullak-Ublick GA; Weiler S
Praxis (Bern 1994); 2015 Oct; 104(21):1129-34. PubMed ID: 26463904
[TBL] [Abstract][Full Text] [Related]
7. Opioid substitution therapy or hidden opioids are a minefield for nalmefene: an atypical case series of 11 patients in Lorraine.
Yéléhé-Okouma M; Martini H; Lemarié J; Labroca P; Petitpain N; Gibaja V; Paille F; Gillet P
Fundam Clin Pharmacol; 2017 Oct; 31(5):574-579. PubMed ID: 28322465
[TBL] [Abstract][Full Text] [Related]
8. Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose.
Krieter P; Gyaw S; Crystal R; Skolnick P
J Pharmacol Exp Ther; 2019 Nov; 371(2):409-415. PubMed ID: 30940694
[TBL] [Abstract][Full Text] [Related]
9. Nalmefene Mistakenly Prescribed to Reduce Alcohol Consumption in Patients Under Buprenorphine Substitution Therapy Resulting in Acute Opioid Withdrawal: Management in an Emergency Setting.
Pélissier F; Rougé Bugat ME; Nubukpo P; Franchitto N
J Clin Psychopharmacol; 2016 Feb; 36(1):100-3. PubMed ID: 26658085
[No Abstract] [Full Text] [Related]
10. [Illogical association nalmefene and opioids: Analysis in the French pharmacovigilance database].
Favrelière S; Lafay-Chebassier C; Fauconneau B; Quillet A; Yéléhé-Okouma M; Montastruc F; Pérault-Pochat MC
Therapie; 2019 Jun; 74(3):369-374. PubMed ID: 30197228
[TBL] [Abstract][Full Text] [Related]
11. Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians.
Franchitto N; Jullian B; Salles J; Pelissier F; Rolland B
Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):669-677. PubMed ID: 28343423
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
